Skip to content

    ARS Pharmaceuticals (SPRY) stock price & financials

    View SPRY earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance56.2% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $2.07M
    $86.58M
    $7.97M
    $15.72M
    $32.50M
    +1471.6%
    $28.09M
    -67.6%
    $22.68M
    +184.5%
    $33.66M
    +114.2%
    Strengthening
    Operating Profit
    -$21.75M
    $47.20M
    -$37.18M
    -$47.61M
    -$53.19M
    -144.6%
    -$41.47M
    -187.9%
    -$60.15M
    -61.8%
    -$61.47M
    -29.1%
    Weakening
    Net Profit
    -$19.13M
    $49.93M
    -$33.94M
    -$44.88M
    -$51.15M
    -167.4%
    -$41.32M
    -182.8%
    -$60.62M
    -78.6%
    -$62.34M
    -38.9%
    Weakening
    EPS
    $-0.20
    $-0.35
    $-0.46
    $-0.52
    -160.0%
    $-0.61
    -74.3%
    $-0.63
    -37.0%
    Weakening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    MarginsOPM
    -1051.6%
    54.5%
    -466.3%
    -302.9%
    -163.7%
    +84.4%
    -147.6%
    -370.8%
    -265.2%
    +43.1%
    -182.6%
    +39.7%
    Weakening
    Tax
    ReturnsROIC
    4.6%
    -12.0%
    8.1%
    10.7%
    12.3%
    +167.4%
    9.9%
    14.5%
    +78.6%
    14.9%
    +38.9%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$386.57M$60.06M$210.52M$70.97M$50.82M$41.32M$8.16M
    Short-Term Investments
    Total Current Assets$390.66M$60.73M$277.70M$231.73M$334.30M$284.90M$211.51M
    Net PP&E$3.80M$693.0K$774.0K$824.0K$1.10M$2.46M$2.08M
    Goodwill
    Intangibles$0$7.37M$14.45M$13.90M
    Total Assets$394.80M$61.45M$281.44M$233.19M$351.15M$327.65M$249.50M
    LiabilitiesTotal Current Liabilities$9.60M$8.19M$5.44M$2.39M$23.44M$39.15M$60.86M
    Short-Term Debt
    Long-Term Debt$0$96.37M$96.68M
    Long-Term Leases$2.33M$480.0K$251.0K$37.0K$0
    Total Liabilities$11.93M$16.68M$8.55M$2.43M$94.36M$213.39M$236.98M
    EquityCommon Stock & APIC$3.0K$3.0K$9.0K$10.0K$10.0K$10.0K$10.0K
    Retained Earnings-$96.73M-$42.26M-$76.94M-$131.30M-$123.31M-$294.60M-$417.56M
    Total Equity-$14.05M-$31.27M$272.89M$230.76M$256.80M$114.26M$12.51M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$31.20M-$17.56M-$40.08M-$59.27M$13.55M-$170.87M-$196.41M
    Cash from Investing-$917.0K-$55.0K-$199.0K-$87.18M-$106.10M$56.77M$48.50M
    Cash from Financing$408.51M$53.16M$190.73M$6.90M$72.40M$104.60M$104.53M
    SummaryCapital Expenditure-$917.0K-$55.0K-$199.0K-$175.0K-$563.0K-$339.0K-$197.0K
    Free Cash Flow-$32.11M-$17.62M-$40.28M-$59.44M$12.98M-$171.21M-$196.60M
    FCF Margin-319.9%-3060.6%-198136.7%14.6%-203.1%-168.1%

    Ratios